0001362118-23-000002.txt : 20230105
0001362118-23-000002.hdr.sgml : 20230105
20230105104117
ACCESSION NUMBER: 0001362118-23-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230105
DATE AS OF CHANGE: 20230105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FRIEDEMAN JESSICA
CENTRAL INDEX KEY: 0001960450
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39785
FILM NUMBER: 23510076
MAIL ADDRESS:
STREET 1: C/O LIFEMD
STREET 2: 236 FIFTH AVENUE, SUITE 400
CITY: NEW YORK
STATE: NY
ZIP: 10001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LifeMD, Inc.
CENTRAL INDEX KEY: 0000948320
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 760238453
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 236 FIFTH AVENUE
STREET 2: SUITE 400
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: (866) 351-5907
MAIL ADDRESS:
STREET 1: 236 FIFTH AVENUE
STREET 2: SUITE 400
CITY: NEW YORK
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: CONVERSION LABS, INC.
DATE OF NAME CHANGE: 20180622
FORMER COMPANY:
FORMER CONFORMED NAME: Immudyne, Inc.
DATE OF NAME CHANGE: 20120514
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUDYNE INC
DATE OF NAME CHANGE: 19950720
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2023-01-03
0
0000948320
LifeMD, Inc.
LFMD
0001960450
FRIEDEMAN JESSICA
C/O LIFEMD
236 FIFTH AVENUE, SUITE 400
NEW YORK
NY
10001
0
1
0
0
Chief Marketing Officer
Common Stock
2023-01-03
4
A
0
150000
A
150000
D
Pursuant to the Company's 2020 Equity and Incentive Plan, as amended, the reporting person received a grant of 150,000 restricted shares, with 50,000 vesting on January 3, 2024, 50,000 vesting on January 3, 2025 and 50,000 vesting on January 3, 2026.
/s/ Jessica Friedeman
2023-01-05